InvestorsHub Logo
Followers 22
Posts 996
Boards Moderated 0
Alias Born 08/01/2016

Re: None

Thursday, 10/15/2020 10:03:34 AM

Thursday, October 15, 2020 10:03:34 AM

Post# of 700284
Someone posted this on Yahoo
The article below is from Joan Lappin...who Newsweek Business refers to as an investment guru

"Right now, NWBO is valued at less than $1 billion. If the trial is successful, and we will know quickly, this undervaluation will correct rapidly. Immunomedics was recently acquired for $21 billion by Gilead with a less promising drug. Like all biotech trials, this one can still fail. Do not spend more money than you can afford to lose but understand that this drug has the potential to alter all solid tumor cancer treatment for years to come."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News